World’s largest respiratory genetics study launches on World COPD Day
Researchers from the Universities of Nottingham and Leicester are leading the largest ever study of the genetics relating to lung disease.
Researchers from the Universities of Nottingham and Leicester are leading the largest ever study of the genetics relating to lung disease.
Deliberately inflicting carefully controlled painful stimuli on human volunteers and seeing how well specific drugs reduce the feeling of pain can be an effective way of testing new… read more.
Companionship has the potential to reduce pain linked to nerve damage, according to a new study.
Liposomes packed with local anesthetic could block the nerve signals that reprogram pain centers and cause chronic, debilitating pain.
Nonsteroidal anti-inflammatory drugs, especially aspirin, may help prevent serious liver problems, a large observational study suggested.
Nonsteroidal anti-inflammatory drugs, especially aspirin, may help prevent serious liver problems, a large observational study suggested.
A new iPhone app developed at the University of Michigan lets migraine or facial pain patients easily track and record their pain, which in turn helps the treating… read more.
Lower extremity pain linked to poor physical and mental health in overweight kids.
While scientific evidence suggests that less is typically more when it comes to diagnosing and treating low-back pain in the US, the number of expensive imaging exams and… read more.
The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic… read more.
An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3… read more.
by Gary Finnegan – EMA Highlights – The EMA has given the green light to a new vaccine for bacterial meningitis. Bexsero, by Novartis, provides broad coverage against… read more.
Advertisment